117 related articles for article (PubMed ID: 32363379)
1. The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients.
Yamaguchi H; Honda M; Hamada K; Kobayashi H; Todate Y; Seto I; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M
Jpn J Clin Oncol; 2020 Aug; 50(8):903-908. PubMed ID: 32363379
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy for liver metastases from gastric cancer.
Fukumitsu N; Okumura T; Takizawa D; Numajiri H; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
J Radiat Res; 2017 May; 58(3):357-362. PubMed ID: 27974509
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Todate Y; Ishikawa Y; Seto I; Tominaga T; Machida M; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M; Konno S
Strahlenther Onkol; 2023 Mar; 199(3):304-312. PubMed ID: 36446925
[TBL] [Abstract][Full Text] [Related]
5. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
7. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
9. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
[TBL] [Abstract][Full Text] [Related]
10. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
[TBL] [Abstract][Full Text] [Related]
11. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
[TBL] [Abstract][Full Text] [Related]
12. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer.
Kim TH; Lee WJ; Woo SM; Kim H; Oh ES; Lee JH; Han SS; Park SJ; Suh YG; Moon SH; Kim SS; Kim DY
Technol Cancer Res Treat; 2018 Jan; 17():1533033818783879. PubMed ID: 29962281
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Kim K; Yu JI; Park HC; Yoo GS; Lim DH; Noh JM; Jeong WK
Radiother Oncol; 2022 Nov; 176():9-16. PubMed ID: 36113779
[TBL] [Abstract][Full Text] [Related]
17. Concurrent proton beam radiotherapy and systemic chemotherapy for the metastatic liver tumor of gastric carcinoma: a case report.
Gohongi T; Tokuuye K; Iida H; Nakai R; Gunji N; Akine Y; Orii K
Jpn J Clin Oncol; 2005 Jan; 35(1):40-4. PubMed ID: 15681604
[TBL] [Abstract][Full Text] [Related]
18. Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
Hong TS; Wo JY; Borger DR; Yeap BY; McDonnell EI; Willers H; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Tanguturi S; Goyal L; Murphy JE; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Tanabe KK; Ferrone CR; Ryan DP; Iafrate AJ; DeLaney TF; Zhu AX
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954285
[TBL] [Abstract][Full Text] [Related]
19. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146
[TBL] [Abstract][Full Text] [Related]
20. Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
Takaoka EI; Miyazaki J; Ishikawa H; Kawai K; Kimura T; Ishitsuka R; Kojima T; Kanuma R; Takizawa D; Okumura T; Sakurai H; Nishiyama H
Jpn J Clin Oncol; 2017 Jan; 47(1):67-73. PubMed ID: 27737963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
